FindTrial
Sign In

Effect of cholesterol lowering drugs(statins) on blood sugar levels in non diabetic patients.

Analysis of glycemic status in diabetes naïve patients on statins - A Hospital based Cross Sectional Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/05/014275
Enrollment
104
Registered
2018-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Non Diabetic patients on statins taken from the cardiology OPD.

Interventions

None listed

Sponsors

Kasturba hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients above 30 years 2)Patients of either sex 3)Patients on statins for at least one year. 4)Non diabetic patients with fasting blood glucose <100mg/dl at the time of onset of statins.

Exclusion criteria

Exclusion criteria: 1)Diabetic patients. 2)Patients on any concomitant medications thatmay raise blood glucose levels like fluoroquinolones, beta blockers, atypical antipsychotics, glucocorticoids, thiazide diuretics and proteasae inhibitors. 3)Pregnant and lactating women. 4)Morbid obesity i.e. BMI >30kg/m2

Design outcomes

Primary

MeasureTime frame
1)No. of patients with new onset diabetes defined as Fasting blood sugar â?¥126 mg/dl. OR Those with pre diabetes i.e. fasting blood glucoseâ?¥110 mg/dl and 126 mg/dl. 2)Using the fasting blood glucose levels and insulin values, beta cell functioning, insulin resistance will be determined using HOMA and insulin sensitivity using QUICKI will be determined. Timepoint: Time Point: Patients were assessed at least after 1 year of statin usage.—

Secondary

MeasureTime frame
1. To find out the prevalence of risk factors such as age, sex and weight among statin users developing hyperglycemia. 2. To analyze the outcome of statins on beta cell functioning and insulin resistance using Homeostatic Model Assessment (HOMA) 3. To analyze the outcome of statins on insulin sensitivity using Quantitative Insulin Sensitivity Check Index (QUICKI) 4. To study the other side effects associated with statins. Timepoint: 1. To find out the prevalence of risk factors such as age, sex and weight among statin users developing hyperglycemia. 2. To analyze the outcome of statins on beta cell functioning and insulin resistance using Homeostatic Model Assessment (HOMA) 3. To analyze the outcome of statins on insulin sensitivity using Quantitative Insulin Sensitivity Check Index (QUICKI) 4. To study the other side effects associated with statins.—

Countries

India

Contacts

Public ContactDr Bharti Chogtu Magazine

Kasturba Medical College, Manipal

bhartimagazine@gmail.com9901728668

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026